Related references
Note: Only part of the references are listed.Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function of HER2 and TOP2A Status
Raymond Tubbs et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
F. P. O'Malley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial
John M. S. Bartlett et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer:: A pooled analysis of randomized trials
Alessandra Gennari et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
HER2/neu in systemic therapy for women with breast cancer:: a systematic review
Bindi Dhesy-Thind et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
Christopher J. Poole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
HER2 and responsiveness of breast cancer to adjuvant chemotherapy
KI Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil:: Danish Breast Cancer Cooperative Group
AS Knoop et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer
M De Laurentiis et al.
CLINICAL CANCER RESEARCH (2005)
HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel
A Di Leo et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15
S Paik et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
